» Articles » PMID: 20028010

Isolation and Identification of Chlorinated Genistein from Actinoplanes Sp. HBDN08 with Antioxidant and Antitumor Activities

Overview
Date 2009 Dec 24
PMID 20028010
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

A strain Actinoplanes sp. HBDN08 was screened by PCR-guided method using primers derived from conserved regions of halogenase genes. A new chlorinated isoflavone, 3',8-dichlorogenistein (1), along with 8-chlorogenistein (2) were isolated from the fermentation broth of Actinoplanes sp. HBDN08. Their structures were elucidated on the basis of extensive 1D and 2D NMR as well as HRESI-MS, ESI-MS, UV, and IR spectroscopic analyses. The origin of the two compounds was also investigated by high-performance liquid chromatography (HPLC) analysis. The results demonstrated that they were not biosynthesized but derived from the biotransformation of genistein by Actinoplanes sp. HBDN08. The antioxidant activities of the isolated compounds 1 and 2 were evaluated by using the lipid peroxidation assay. Their antitumor activities were calculated according to the inhibitory rate of cell proliferation against the human breast cancer cell line MDA-MB-231. The results indicated that compounds 1 (IC(50) = 5.2 microM) and 2 (IC(50) = 7.5 microM) showed stronger antioxidant activities than genistein (IC(50) = 13.6 microM). In comparison with the antitumor activities of genistein, those of compounds 1 and 2 increased 7.7- and 2.6-fold, respectively. These results suggest that the PCR-guided screening strategy is a rapid method for obtaining halometabolite-producing strains. Moreover, these results reveal that chlorination has significant effects on the bioactivities of genistein. This could be important information for studying the structure-activity relationships of genistein.

Citing Articles

Therapeutic potential of flavonoids in gastrointestinal cancer: Focus on signaling pathways and improvement strategies (Review).

Ding Y, Yu Y Mol Med Rep. 2025; 31(4).

PMID: 40017144 PMC: 11884236. DOI: 10.3892/mmr.2025.13474.


Discovery of thiazostatin D/E using UPLC-HR-MS2-based metabolomics and σ-factor engineering of sp. SE50/110.

Schluter L, Hansen K, Isaksson J, Hammer Andersen J, Hansen E, Kalinowski J Front Bioeng Biotechnol. 2024; 12:1497138.

PMID: 39654828 PMC: 11626248. DOI: 10.3389/fbioe.2024.1497138.


Current Techniques of Water Solubility Improvement for Antioxidant Compounds and Their Correlation with Its Activity: Molecular Pharmaceutics.

Budiman A, Rusdin A, Aulifa D Antioxidants (Basel). 2023; 12(2).

PMID: 36829937 PMC: 9952677. DOI: 10.3390/antiox12020378.


The secondary metabolites of rare actinomycetes: chemistry and bioactivity.

Ding T, Yang L, Zhang W, Shen Y RSC Adv. 2022; 9(38):21964-21988.

PMID: 35518871 PMC: 9067109. DOI: 10.1039/c9ra03579f.


Bioprospecting potential of halogenases from Arctic marine actinomycetes.

Liao L, Chen R, Jiang M, Tian X, Liu H, Yu Y BMC Microbiol. 2016; 16:34.

PMID: 26964536 PMC: 4785625. DOI: 10.1186/s12866-016-0662-2.